600671.SHG Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
17.03 CNY
Close of Nov 4, 2026
15.70 24.25
Market cap
CNY 2.07B
P/E
189.2x
P/B
26.46x
ROE
13.8%
Dividend yield
0.31%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600671.SHG undervalued?

Graham number

The Graham number of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd fundamental analysis

No fundamental analysis for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd yet.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces tablets, granules, pills, oral solutions, and other medications; and health food products, including oral liquids, syrups, eye drops, pills, soft capsules, tablets, and granules. It also sells prepared slices of traditional Chinese medicine. In addition, the company operates Chinese …

Full company profile